Grifols' Biotest Set to Launch Intravenous Immunoglobulin in US in Q1 2025
Grifols' Biotest Set to Launch Intravenous Immunoglobulin in US in Q1 2025
基立福生物即将在2025年第一季度在美国推出静脉免疫球蛋白
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册